KGKarlina García-Sosa

Karlina García-Sosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karlina García-Sosa has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A New Bioactive Cardenolide from Nerium oleander

    by Ismael Fernando Villegas-Acosta, Guadalupe Ayora-Talavera, Karlina Garcia-Sosa, Emanuel Hernández-Núñez, Víctor Manuel Aguilar-Hernández, Luis Manuel Peña-Rodriguez

  • Bioassay-guided identification of antithrombotic compounds from Cnidoscolus aconitifolius (Mill.) I. M. Jhonst.: molecular docking, bioavailability, and toxicity prediction

    by Juan Pablo Quintal Martínez, Irma Guadalupe Quintal Ortiz, Ligia Gabriela Alonso Salomón, Karlina García-Sosa, Luis Manuel Peña Rodríguez, José Antonio Guerrero Analco, Juan Luis Monribot Villanueva, Abraham Marcelino Vidal Limón, Maira Rubi Segura Campos

    Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Conventional antithrombotic therapy has reported hemorrhagic accidents. Ethnobotanical and scientific reports point to Cnidoscolus aconitifolius as an antithrombotic adjuvant. Previously, C. aconitifolius leaves ethanolic extract displayed antiplatelet, anticoagulant, and fibrinolytic activities. This work aimed to identify compounds from C. aconitifolius with in vitro antithrombotic activity through a bioassay-guided study. Antiplatelet, anticoagulant, and fibrinolytic tests guided the fractionation. Ethanolic extract was subjected to a liquid-liquid partitioning, followed by vacuum liquid, and size exclusion chromatography to obtain the bioactive JP10B fraction. The compounds were identified through UHPLC-QTOF-MS, and their molecular docking, bioavailability, and toxicological parameters were determined computationally. Kaempferol-3-O-glucorhamnoside and 15(S)-HPETE were identified; both showed affinity for antithrombotic targets, low absorption, and safety for human consumption. Further in vitro and in vivo evaluations will better understand their antithrombotic mechanism. This bioassay-guided fractionation demonstrated that C. aconitifolius ethanolic extract has antithrombotic compounds.Communicated by Ramaswamy H. Sarma.


  • Clusia suborbicularis is not a synonym of Clusia flava: Molecular and metabolomic evidence

    by Luis Alfredo Herbert‐Doctor, Gabriel Dzib, Barry Edward Hammel, Bartolomé Humberto Chi‐Manzanero, Blondy Beatriz Canto‐Canché, Karlina García‐Sosa, Pascal Richomme, Séverine Derbré, Luis Manuel Peña‐Rodríguez

    The genus Clusia (Clusiaceae) is notorious for its difficult taxonomy; most species are dioecious, with distantly related species having similar morphology, and closely related species having cryptic morphological differences. Because of this, Clusia spp. are often misidentified or, as in the case of C. suborbicularis and C. flava, considered to be the same species. Chemometric analyses of the HPLC metabolic profiles from bark extracts of C. suborbicularis and C. flava, combined with molecular evidence from ITS molecular markers were used to establish the metabolomic similarities and phylogenetic relationship between C. suborbicularis and C. flava, previously identified on the basis of their morphological characteristics. The principal component analyses of the HPLC metabolic profiles of bark extracts from individuals of C. suborbicularis and C. flava showed significant differences, suggesting they should be recognized as distinct species. This assumption was confirmed by phylogenetic reconstructions based on the molecular marker ITS. Furthermore, a theoretical geographical distribution analysis suggests C. suborbicularis could be considered a native species to the Yucatán Peninsula. The results from this investigation support C. suborbicularis as a distinct species, and not a synonym of C. flava. The identification of these two species represents a relevant contribution for the cataloguing, conservation and bioprospecting of Clusia spp. occurring in the Yucatán Peninsula.


  • Open Access

    In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis

    by Angel de Jesús Dzul-Beh, Karlina García-Sosa, Andrés Humberto Uc-Cachón, Jorge Bórquez, Luis A. Loyola, Hugo B. Barrios-García, Luis Manuel Peña-Rodríguez, Gloria María Molina-Salinas